Search
Patexia Research
Case number 2021-1038

Neurelis, Inc. v. Aquestive Therapeutics, Inc. > Documents

Date Field Doc. No.Description (Pages)
Nov 15, 2021 51 Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [812145] [MVH] [Entered: 11/15/2021 10:28 AM] (1)
Oct 10, 2021 0 NEURELIS, INC. v. AQUESTIVE THERAPEUTICS, INC. [RULE 36 JUDGMENT] [nonprecedential] (0)
Oct 7, 2021 50 JUDGMENT. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [804250] [MVH] [Entered: 10/07/2021 10:50 AM] (2)
Oct 5, 2021 49 Submitted after ORAL ARGUMENT to Panel: Moore, Chief Judge; Newman, Circuit Judge and Reyna, Circuit Judge.Arguing counsel: Wendy L. Devine for Neurelis, Inc. and Daniel A. Scola, Jr. for Aquestive Therapeutics, Inc.Oral Argument Audio available here. [803785] [JCP] [Entered: 10/05/2021 04:47 PM] (0)
Sep 13, 2021 48 Corrected Response to notice of oral argument from Appellee Aquestive Therapeutics, Inc.. Service: 09/13/2021 by email. [798889] [21-1038] [Daniel Scola] [Entered: 09/13/2021 04:28 PM] (3)
Sep 13, 2021 47 Corrected Response to notice of oral argument from Appellant Neurelis, Inc.. Service: 09/13/2021 by email. [798858] [21-1038] [Wendy Devine] [Entered: 09/13/2021 03:35 PM] (3)
Sep 13, 2021 46 NOTICE OF NON-COMPLIANCE: The submission of Neurelis, Inc., Response to Notice of Oral Argument [43], is not in compliance with the rules of this court (see attached). Compliant document due 09/20/2021. Service as of this date by the Clerk of Court. [798807] [MJL] [Entered: 09/13/2021 02:10 PM] (1)
Sep 13, 2021 45 NOTICE OF NON-COMPLIANCE: The submission of Aquestive Therapeutics, Inc., Response to Notice of Oral Argument [44], is not in compliance with the rules of this court (see attached). Compliant document due 09/20/2021. Service as of this date by the Clerk of Court. [798800] [MJL] [Entered: 09/13/2021 02:03 PM] (1)
Aug 30, 2021 44 Response to notice of oral argument from Appellee Aquestive Therapeutics, Inc.. Service: 08/30/2021 by email. [796059] [21-1038]. This document is non-compliant. See Doc. No. [45]. [Michael Chakansky] [Entered: 08/30/2021 03:49 PM] (3)
Aug 26, 2021 43 Response to notice of oral argument from Appellant Neurelis, Inc.. Service: 08/26/2021 by email. [795338] [21-1038]. This document is non-compliant. See Doc. No. [46]. [Richard Torczon] [Entered: 08/26/2021 09:08 AM] (3)
Aug 20, 2021 42 NOTICE OF ORAL ARGUMENT. Panel: 2110E. Case scheduled October 5, 2021. Response to Notice of Oral Argument due: 09/15/2021. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [794457] [MVH] [Entered: 08/20/2021 04:39 PM] (2)
Jul 12, 2021 41 The following conflict dates submitted by Wendy L. Devine for Neurelis, Inc. have been accepted by the court: 08/30/2021, 08/31/2021, 09/01/2021, 09/02/2021, 09/03/2021. [785486] [MJL] [Entered: 07/12/2021 09:48 AM] (0)
Jul 6, 2021 40 Notice from Appellant Neurelis, Inc. regarding conflicts with oral argument. Service: 07/06/2021 by email. [784260] [21-1038] [Wendy Devine] [Entered: 07/06/2021 01:35 PM] (3)
May 19, 2021 39 6 paper copies of Doc. No. [33], [29], [16] received from Appellant Neurelis, Inc.. [776214] [VDW] [Entered: 05/20/2021 11:51 AM] (0)
May 19, 2021 38 Notice from Appellee Aquestive Therapeutics, Inc. regarding conflicts with oral argument. None. Service: 05/19/2021 by email. [775977] [21-1038] [Michael Chakansky] [Entered: 05/19/2021 01:07 PM] (0)
May 18, 2021 37 Notice from Appellant Neurelis, Inc. regarding conflicts with oral argument. Service: 05/18/2021 by email. [775825] [21-1038] [Richard Torczon] [Entered: 05/18/2021 06:36 PM] (3)
May 13, 2021 36 6 paper copies of Doc. No. [21] received from Appellee Aquestive Therapeutics, Inc.. [775723] [VDW] [Entered: 05/18/2021 02:11 PM] (0)
May 12, 2021 35 Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [774456] [EKD] [Entered: 05/12/2021 09:54 AM] (1)
May 12, 2021 34 Notice to counsel: The Clerk's Office directs that outstanding paper copies of all briefs and appendices in this case must be submitted on or before May 19, 2021. See Administrative Order No. 20-01 (Mar. 20, 2020). [774455] [EKD] [Entered: 05/12/2021 09:53 AM] (0)
May 11, 2021 33 MODIFIED ENTRY: CORRECTED APPENDIX FILED by Appellant Neurelis, Inc. Service: 05/11/2021 by email. [774336] --[Edited 05/12/2021 by EKD - compliance review complete] [Richard Torczon] [Entered: 05/11/2021 03:25 PM] (744)
May 11, 2021 32 NOTICE OF NON-COMPLIANCE: The submission of Appellant Neurelis, Inc., Appendix [30], is not in compliance with the rules of this court (see attached). Compliant document is due on 05/18/2021. Service as of this date by the Clerk of Court. [774288] [EKD] [Entered: 05/11/2021 01:23 PM] (1)
May 10, 2021 31 Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Neurelis, Inc.. Service: 05/10/2021 by email. [774115] [21-1038] [Richard Torczon] [Entered: 05/10/2021 04:11 PM] (5)
May 10, 2021 30 APPENDIX FILED by Appellant Neurelis, Inc. Service: 05/10/2021 by email. [774114] [21-1038] This document is non-compliant. See Doc No. [32] [Richard Torczon] [Entered: 05/10/2021 04:10 PM] (739)
May 3, 2021 29 MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Neurelis, Inc. Service: 05/03/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [772520] --[Edited 05/03/2021 by EKD - compliance review complete] [Richard Torczon] [Entered: 05/03/2021 01:34 PM] (25)
Apr 16, 2021 28 **TEXT ONLY** ORDER granting motion to withdraw Jeffrey Guise as principal counsel [22] filed by Appellant Neurelis, Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [769249] [EKD] [Entered: 04/16/2021 12:09 PM] (0)
Apr 14, 2021 27 **TEXT ONLY** ORDER granting motion to extend time to file brief [24] filed by Appellant Neurelis, Inc. The reply brief is due 05/03/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [768507] [EKD] [Entered: 04/14/2021 10:46 AM] (0)
Apr 13, 2021 26 Corrected Entry of appearance for Wendy Devine as counsel for Appellant Neurelis, Inc.. Service: 04/13/2021 by email. [768355] [21-1038] [Wendy Devine] [Entered: 04/13/2021 02:51 PM] (1)
Apr 13, 2021 25 NOTICE OF NON-COMPLIANCE: The submission of Appellant Neurelis, Inc., Entry of Appearance [23], is not in compliance with the rules of this court (see attached). Compliant document is due on 04/20/2021. Service as of this date by the Clerk of Court. [768178] [EKD] [Entered: 04/13/2021 08:56 AM] (1)
Apr 12, 2021 24 MOTION of Appellant Neurelis, Inc. to extend the time to 05/03/2021 to file brief. Service: 04/12/2021 by email. [768071] [21-1038] [Richard Torczon] [Entered: 04/12/2021 03:41 PM] (5)
Apr 6, 2021 23 Entry of appearance for Wendy Devine as counsel for Appellant Neurelis, Inc.. Service: 04/06/2021 by email. [767109] [21-1038] [Wendy Devine] [Entered: 04/06/2021 06:16 PM] (0)
Apr 6, 2021 22 MOTION of Appellant Neurelis, Inc. to withdraw counsel Jeffrey Guise. Service: 04/06/2021 by email. [767107] [21-1038] [Wendy Devine] [Entered: 04/06/2021 06:12 PM] (0)
Mar 31, 2021 21 MODIFIED ENTRY: CORRECTED RESPONSE BRIEF FILED by Appellee Aquestive Therapeutics, Inc. Service: 03/31/2021 by email. [765925] --[Edited 04/01/2021 by EKD - compliance review complete] [Michael Chakansky] [Entered: 03/31/2021 12:33 PM] (0)
Mar 31, 2021 20 NOTICE OF NON-COMPLIANCE: The submission of Appellee Aquestive Therapeutics, Inc., Response Brief [19], is not in compliance with the rules of this court (see attached). Compliant document is due on 04/07/2021. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [765874] [EKD] [Entered: 03/31/2021 10:35 AM] (0)
Mar 29, 2021 19 RESPONSE BRIEF FILED by Appellee Aquestive Therapeutics, Inc. Service: 03/29/2021 by email. [765407] [21-1038] This document is non-compliant. See Doc No. [20] [Michael Chakansky] [Entered: 03/29/2021 02:17 PM] (0)
Feb 25, 2021 18 **TEXT ONLY** ORDER granting motion to extend time to file brief [17] filed by Appellee Aquestive Therapeutics, Inc. The response brief is due 03/29/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [758503] [EKD] [Entered: 02/25/2021 08:27 AM] (0)
Feb 24, 2021 17 MOTION of Appellee Aquestive Therapeutics, Inc. to extend the time to 03/29/2021 to file brief. Service: 02/24/2021 by email. [758417] [21-1038] [Michael Chakansky] [Entered: 02/24/2021 04:23 PM] (0)
Feb 2, 2021 16 MODIFIED ENTRY: BRIEF FILED by Appellant Neurelis, Inc. Service: 02/02/2021 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [753475] --[Edited 02/04/2021 by EKD - compliance review complete] [Richard Torczon] [Entered: 02/02/2021 03:49 PM] (0)
Jan 13, 2021 15 **TEXT ONLY** ORDER granting motion to extend time to file brief [14] filed by Appellant Neurelis, Inc. The opening brief is due 02/02/2021. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [748949] [EKD] [Entered: 01/13/2021 08:42 AM] (0)
Jan 12, 2021 14 MOTION of Appellant Neurelis, Inc. to extend the time to 02/02/2021 to file brief. Service: 01/12/2021 by email. [748736] [21-1038] [Richard Torczon] [Entered: 01/12/2021 12:12 PM] (0)
Nov 18, 2020 13 Certified list received. Service: 11/18/2020 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [736652] [EKD] [Entered: 11/18/2020 01:00 PM] (81)
Nov 9, 2020 12 ORDER granting motion to extend time to file [10] filed by Appellant Neurelis, Inc. ECF No. 11 is accepted for filing as a corrected entry of appearance for Neurelis, Inc. Service as of this date by the Clerk of Court. [734482] [LMS] [Entered: 11/09/2020 12:32 PM] (2)
Nov 3, 2020 11 Corrected Entry of appearance for Jeffrey Guise; Richard Torczon; Wendy Devine; Lorelei Perez Westin as counsel for Appellant Neurelis, Inc.. Service: 11/03/2020 by email. [733302] [21-1038] [Richard Torczon] [Entered: 11/03/2020 12:47 PM] (2)
Nov 3, 2020 10 MOTION of Appellant Neurelis, Inc. to extend time. Service: 11/03/2020 by email. [733299] [21-1038] [Richard Torczon] [Entered: 11/03/2020 12:45 PM] (9)
Oct 27, 2020 9 Corrected Entry of appearance for Daniel A. Scola, Jr.; Michael I. Chakansky; John T. Gallagher as counsel for Appellee Aquestive Therapeutics, Inc.. Service: 10/27/2020 by email. [731617] [21-1038] [Michael Chakansky] [Entered: 10/27/2020 11:17 AM] (2)
Oct 26, 2020 8 NOTICE OF NON-COMPLIANCE: The submissions of Appellant Neurelis, Inc. and Appellee Aquestive Therapeutics, Inc., Entries of Appearance [2], [5], are not in compliance with the rules of this court (see attached). Compliant documents are due on 11/02/2020. Service as of this date by the Clerk of Court. [731383]--[Edited 11/05/2020 by EKD to correct docket text] [EKD] [Entered: 10/26/2020 01:51 PM] (2)
Oct 23, 2020 7 Docketing Statement for the Appellee Aquestive Therapeutics, Inc.. Service: 10/23/2020 by email. [731011] [21-1038] [Michael Chakansky] [Entered: 10/23/2020 10:46 AM] (2)
Oct 23, 2020 6 Certificate of Interest for Appellee Aquestive Therapeutics, Inc.. Service: 10/23/2020 by email. [731009] [21-1038] [Michael Chakansky] [Entered: 10/23/2020 10:42 AM] (3)
Oct 23, 2020 5 Entry of appearance for Daniel A. Scola, Jr.; Michael I. Chakansky; John T. Gallagher as counsel for Appellee Aquestive Therapeutics, Inc. Service: 10/23/2020 by email. [731007] [21-1038] This document is non-compliant. See Doc No. [8] [Michael Chakansky] [Entered: 10/23/2020 10:36 AM] (2)
Oct 23, 2020 4 Docketing Statement for the Appellant Neurelis, Inc.. Service: 10/23/2020 by email. [730998] [21-1038] [Richard Torczon] [Entered: 10/23/2020 10:09 AM] (2)
Oct 23, 2020 3 Certificate of Interest for Appellant Neurelis, Inc.. Service: 10/23/2020 by email. [730995] [21-1038] [Richard Torczon] [Entered: 10/23/2020 10:03 AM] (3)
Oct 23, 2020 2 Entry of appearance for Jeffrey Guise; Richard Torczon; Wendy Devine; Lorelei P. Westin as counsel for Appellant Neurelis, Inc. Service: 10/23/2020 by email. [730994] [21-1038] This document is non-compliant. See Doc No. [8] [Richard Torczon] [Entered: 10/23/2020 10:01 AM] (2)
Oct 9, 2020 1 Appeal docketed. Received: 10/08/2020. [727967] Entry of Appearance is due on 10/23/2020. Certificate of Interest is due on 10/23/2020. Docketing Statement is due on 10/23/2020. Certified List is due on 11/18/2020. [EKD] [Entered: 10/09/2020 04:04 PM] (79)
Menu